INBX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Inhibrx Biosciences Inc (INBX) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock lacks strong positive catalysts, has weak financial performance, and no significant trading signals or trends. A hold is recommended until clearer signals or improved fundamentals emerge.
The technical indicators suggest a weak trend. The MACD is negative and expanding downward (-0.968), indicating bearish momentum. RSI is neutral at 29.053, and moving averages are converging, showing no clear direction. The stock is trading near its S1 support level (70.966), with resistance at R1 (81.158).
NULL. There are no recent news events, insider trades, or hedge fund activity to act as a positive catalyst.
The company's financial performance is weak, with a significant drop in net income (-19.62% YoY) and EPS (-19.72% YoY). Additionally, there are no recent congress trades or analyst upgrades to support the stock.
In 2025/Q3, revenue remained at $0 (0% YoY growth), net income dropped to -$35.26M (-19.62% YoY), and EPS decreased to -2.28 (-19.72% YoY). Gross margin remained at 100%, but the overall financials indicate poor performance.
No recent analyst rating changes or price target updates are available for INBX.
